Hyperkalemia, conversely, arises most commonly in patients with chronic kidney disease, metabolic acidosis, or those receiving potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin II receptor blockers (ARBs). Here, ACE is linked to metabolic acidosis.